EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

A Comprehensive Assessment of Renal Function During and After Pulsed Field Ablation

Václav Melenovský iD, Marek Hozman, Sabri Hassouna, Ivana Fišerová, Barbora Bačová iD, Dalibor Heřman iD, Jakub Karch, Jana Veselá, Michal Zuzčák, Ivan Rychlík, Pavel Osmančík

Journal of Cardiovascular Electrophysiology · 2026-06 · 37 (6) · 1259-1267

DOI: 10.1111/jce.70281 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of Cardiovascular Electrophysiology, online erschienen am 14.04.2026. Verfasst von Václav Melenovský und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, University Hospital Kralovske Vinohrady, 3rd Faculty of Medicine, Charles University, Prague, Czech Republic. Hauptthemen laut MEDLINE: Atrial Fibrillation, Acute Kidney Injury, Kidney, Catheter Ablation. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Institutional Support of Charles University, Prague.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Acute kidney injury is an uncommon complication of pulsed field ablation (PFA). There is, however, limited empirical data on the dynamics of renal biomarkers apart from creatinine. Furthermore, no study to date has assessed creatinine at more than 24 h after the procedure.

Methods

Patients undergoing PFA for atrial fibrillation (AF) were enrolled in a prospective observational study. The ablation was performed using the Farawave pentaspline catheter along with the Farapulse system and consisted of pulmonary vein isolation along with additive lesions in patients with persistent AF and/or atrial flutter. Administration of 500–1000 mL of crystalloid was a mandatory part of the periprocedural management protocol. Before and 24 h after the procedure, serum renal biomarkers were measured (urea, creatinine, cystatin C, NGAL, and KIM‐1), and urinalysis was performed. Hemolysis indices (haptoglobin, Lactate Dehydrogenase, and red blood cell microparticles) were measured after the procedure. Patients were instructed to undergo blood sampling for creatinine and urea 48 h after the procedure.

Results

Samples from 88 patients were analyzed (mean age 67 ± 8.8 years, 33% female, 53% paroxysmal AF, average of 63 [IQR: 40–77] applied pulses). The creatinine concentration at 24 h decreased from 86 (IQR: 72–100) to 82 (IQR: 68–92) µmol/L ( p < 0.001), the concentration at 48 h was similar to preprocedural values (83 [IQR: 69–100] µmol/L; ( p = 1.00). However, 9 patients (10.2%) met AKI criteria; in six of them, AKI was only detectable at the 48‐h measurement. Serum cystatin‐C levels remained unchanged, and urea and urinary erythrocytes increase significantly from baseline to 24 h. NGAL levels increased significantly from 121 (IQR: 86–173) to 143 (IQR: 112–198) at 24 h while changes in KIM‐1 were unsignificant. All changes in renal function were transient and did not require hospitalization. Logistic regression identified age and the total number of pulsed field pulses as the major risk factors for AKI.

Conclusions

Routine PFA with periprocedural hydration and an average of 63 PF pulses appears safe in patients without significant preexisting renal disease, with a low risk of clinically relevant renal impairment. However, the incidence of AKI in our cohort was higher than previously reported, suggesting that transient kidney function changes may be more common than recognized. These findings highlight the need for kidney function monitoring beyond 24 h in higher‐risk patients undergoing PFA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationAcute Kidney InjuryKidneyCatheter AblationPulmonary VeinsHumansFemaleMaleBiomarkersProspective StudiesMiddle AgedAgedCreatinineTreatment OutcomeTime FactorsRisk FactorsIrreversible Electroporation TherapyUreaPredictive Value of TestsKidney Function Tests

Stichwörter der Autor:innen

acute kidney injuryatrial fibrillationcatheter ablationhemepulsed‐field ablation

Substanzen

BiomarkersCreatinineUrea

Autor:innen und Institutionen

  • Department of Cardiology, University Hospital Kralovske Vinohrady, 3rd Faculty of Medicine, Charles University, Prague, Czech Republic.
  • Department of Biochemistry and Molecular Biology, 3rd Faculty of Medicine, Charles University, Prague, Czech Republic.
  • Department of Laboratory Hematology, Central Laboratories, 3rd Faculty of Medicine, University Hospital Kralovske Vinohrady, Prague, Czech Republic.
  • Departement of Internal Medicine, University Hospital Kralovske Vinohrady, 3rd Faculty of Medicine, Charles University, Prague, Czech Republic.

ORCID-Profile: Václav Melenovský, Barbora Bačová, Dalibor Heřman

Förderung

  • Institutional Support of Charles University, Prague

Zitieren

APA

Melenovský, V., Hozman, M., Hassouna, S., Fišerová, I., Bačová, B., Heřman, D., Karch, J., Veselá, J., Zuzčák, M., Rychlík, I., & Osmančík, P. (2026). A Comprehensive Assessment of Renal Function During and After Pulsed Field Ablation. Journal of Cardiovascular Electrophysiology, 37(6), 1259-1267. https://doi.org/10.1111/jce.70281

Vancouver

Melenovský V, Hozman M, Hassouna S, Fišerová I, Bačová B, Heřman D, et al. A Comprehensive Assessment of Renal Function During and After Pulsed Field Ablation. Journal of Cardiovascular Electrophysiology. 2026;37(6):1259-1267. doi:10.1111/jce.70281

BibTeX
@article{Melenovsk2026,
  author = {Melenovský, Václav and Hozman, Marek and Hassouna, Sabri and Fišerová, Ivana and Bačová, Barbora and Heřman, Dalibor and Karch, Jakub and Veselá, Jana and Zuzčák, Michal and Rychlík, Ivan and Osmančík, Pavel},
  title = {A Comprehensive Assessment of Renal Function During and After Pulsed Field Ablation},
  journal = {Journal of Cardiovascular Electrophysiology},
  year = {2026},
  volume = {37},
  number = {6},
  pages = {1259--1267},
  doi = {10.1111/jce.70281}
}
Kostenlos starten →